Company Filing History:
1 out of 27 
1 out of 1 
1 out of 31 
Years Active: 2020
Title: Eva Prchalova: Innovator in Estrogen-Dependent Disease Research
Introduction
Eva Prchalova is a notable inventor based in Prague, Czech Republic. She has made significant contributions to the field of biochemistry, particularly in the development of selective inhibitors for 17β-hydroxysteroid-dehydrogenases. Her work has implications for the diagnosis and treatment of estrogen-dependent diseases.
Latest Patents
Eva Prchalova holds a patent for "15β-substituted estrone derivatives as selective inhibitors of 17β-hydroxysteroid-dehydrogenases, method of preparation and use thereof." This patent describes 15β-substituted derivatives of estrone, which can be utilized in various therapeutic applications. The compounds are characterized by a general formula where substituents can include C-Calkyl, C-Calkoxy, C-Chalogenalkyl, halogen, and COOR, among others. These innovative compounds may play a crucial role in addressing estrogen-related health issues.
Career Highlights
Throughout her career, Eva has worked at esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and the Institute of Molecular Genetics of the Czech Academy of Sciences. Her research has been pivotal in advancing our understanding of steroid hormone interactions and their effects on human health.
Collaborations
Eva Prchalova has collaborated with notable colleagues, including Martin Kotora and Jerzy Adamski. These partnerships have enriched her research and contributed to the development of her patented innovations.
Conclusion
Eva Prchalova's work exemplifies the intersection of innovation and health science. Her contributions to the field of estrogen-dependent diseases through her patented inventions highlight the importance of research in improving medical outcomes.